Justice Community Overdose Innovation Network II TCU Hub (NCT07528846)
Justice Community Overdose Innovation Network II TCU Hub: TCU Building Resilient Initiatives for Deflection Through Greater Engagement Project (TCU BRIDGE to Deflection Project)
🩺 Plain-English Summary (8th-Grade Level)
The current study proposes to use a Hybrid Type 3 implementation research strategy to: 1) Significantly enhance our understanding of public health outcomes \[e.g., overdose incidents and substance-use (SU)-related Emergency Medical Service (EMS) contacts\] and public safety outcomes (e.g., drug-related arrests) associated with Deflection and Pre-Arrest Diversion initiatives (DPAD, hereafter referred to as Deflection); and 2) Create a lasting contribution to the fields of research focused on SU and the criminal legal system (CLS) by advancing knowledge of effective implementation strategies involving the critical role of community engagement in Deflection. The highly experienced team of Multiple PIs, senior-level collaborators from both Deflection and Community Behavioral Health (CBH), state-level evaluation partners, a national stakeholder advisory group, and CLS and behavioral health partners within each community have teamed up to carry out the proposed project. The study approach uses a hybrid implementation-effectiveness design to examine strategies to improve opioid and stimulant relevant outcomes, and specifically proposes to test the implementation-effectiveness of 2 strategy bundles to promote Deflection models through a CORE community engagement bundle (designed to facilitate community stakeholder engagement) and ENHANCED community engagement bundle (CORE plus a component to systematically involve community advocates) on improving implementation as well as public safety and health outcomes. The proposed randomized control trial includes a total of 20 geographically distinct clinical research performance sites (i.e., 20 communities spanning 5 states; New Mexico, Illinois, Wisconsin, Colorado, and Pennsylvania), with 3-5 communities per state and the inclusion of key CLS and CBH stakeholders within each site. The large scope of the project will maximize potential generalizability of study results and sustainability of implementation strategies.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (33 items).
Location: Texas Christian University — Fort Worth, Texas
Age range: 18 Years
🧪 Interventions in This Study
- Core-interagency community engagement approach (OTHER)
- Enhanced-Core plus community engagement specialist (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Not affiliated with a participating Deflection agency;
- No role in Deflection referral or service delivery;
- Under age 18;
- Unable or unwilling to provide informed consent Clients Inclusion Criteria:
- Aged 18 years or older;
- Enrolled in a Deflection program within a participating community;
- Between 1 and 12 months post-enrollment at time of recruitment;
- Documented history of substance use disorder (SUD) or risk for SUD;
- Priority for individuals reporting opioid and/or stimulant use within the past year;
- Able to complete survey and/or interview; Willing to provide informed consent Exclusion Criteria:
- Under age 18;
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Texas Christian University — Fort Worth, Texas
📞 Contact the Study Coordinator
Phone: (817) 257-5841
Email: a.wiese@tcu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Substance Use Disorder (SUD)
- Real-time Opioid Study — New Haven, Connecticut
- Identifying Substance Use Consequences — Belmont, Massachusetts
- Correctional Service of Canada Pilot Trial of Digital Substance Use Disorder Interventions (PROCESS) — Brantford, Ontario
- Preventing Overdose and Promoting Recovery Through Court Navigation — South Bend, Indiana
- Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START — Columbus, Ohio
Explore by condition: All Substance Use Disorder (SUD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.